Metal complexes of the angiotensin-converting enzyme inhibitor, lisinopril. Solution studies and the crystal and molecular structure of a dimeric copper(II)-lisinopril complex

被引:9
作者
Gonzalez, EB
Farkas, E
Soudi, AA
Tan, T
Yanovsky, AI
Nolan, KB
机构
[1] LAJOS KOSSUTH UNIV,DEPT INORGAN & ANALYT CHEM,H-4010 DEBRECEN,HUNGARY
[2] ROYAL COLL SURGEONS IRELAND,DEPT CHEM,DUBLIN 2,IRELAND
[3] RUSSIAN ACAD SCI,XRAY STRUCT CTR,INST ORGANOELEMENT CPDS,MOSCOW 117813,RUSSIA
来源
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS | 1997年 / 13期
关键词
D O I
10.1039/a701500c
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The binding of the angiotensin-converting enzyme inhibitor lisinopril to zinc(II), copper(II) and nickel(II) has been investigated in solution by pH-metric methods and the crystal structure of the dimeric copper(II)-lisinopril complex, [Cu-2(HA)(2)(H2O)(2)][ClO4](2) (H(4)A(2+) = fully protonated lisinopril), has been determined. In the case of the metal ions investigated a major species present in neutral or weakly acidic solution is M(HA)(+), the formation constants of which suggest that co-ordination to the metal ions occurs through the amino nitrogen, carboxylate oxygen and the amide oxygen atoms. The crystal structure of the dimeric copper complex shows that each copper is in a distorted square-pyramidal environment in which the basal plane is occupied by carboxylate (Cu-O 1.944 Angstrom) and carbonyl (Cu-O 1.996 Angstrom) oxygens, and an amino group nitrogen (Cu-N 1.989 Angstrom) from one ligand as well as the prolyl carboxylate of another ligand (Cu-O 1.909 Angstrom). An aqua ligand Cu-O (2.355 Angstrom) is axially bonded to each copper.
引用
收藏
页码:2377 / 2379
页数:3
相关论文
共 15 条
[1]  
BEAGLEHOLE R, 1993, BASIC EPIDEMIOLOGY, P8
[2]  
DANIELE PG, 1977, ANN CHIM-ROME, V67, P311
[3]  
FARKAS E, 1995, J CHEM SOC DA, P447
[4]  
HANSIN RJ, 1990, J MED CHEM, V33, P1940
[5]  
HATHAWAY BJ, 1987, COMPREHENSIVE COORDI, V5, P619
[6]   PROTEIN CRYSTALLOGRAPHY AND COMPUTER-GRAPHICS TOWARD RATIONAL DRUG DESIGN [J].
HOL, WGJ .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1986, 25 (09) :767-778
[7]  
KISS T, 1990, BIOCOORDINATION CHEM, pCH3
[8]  
Leggett DJ, 1985, Computational Methods for the Determination of Formation Constants
[9]  
Oparil S., 1996, CECIL TXB MED, V20th, P256
[10]   CONFIGURATION AND PREFERENTIAL SOLID-STATE CONFORMATIONS OF PERINDOPRILAT (S-9780) - COMPARISON WITH THE CRYSTAL-STRUCTURES OF OTHER ACE INHIBITORS AND CONCLUSIONS RELATED TO STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
PASCARD, C ;
GUILHEM, J ;
VINCENT, M ;
REMOND, G ;
PORTEVIN, B ;
LAUBIE, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :663-669